Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular thrombosis following acute myocardial infarction

Summary

Left ventricular thrombus (LVT) and rupture are important mechanical complications following myocardial infarction (MI) and are believed to be due to unrelated mechanisms. We studied whether, in fact, wall rupture and LVT are closely related in their pathogenesis with intramural platelet thrombus (IMT) playing a pivotal role. Male 129sv and C57Bl/6 mice underwent operation to induce MI, and autopsy was performed to confirm rupture deaths. Haemodynamic features of rupture events were monitored by telemetry in conscious mice. Detailed histological examination was conducted with special attention to the presence of IMT in relation to rupture location and LVT formation. IMT was detected in infarcted hearts of 129sv (82%) and C57Bl/6 (39%) mice with rupture in the form of a narrow streak spanning the wall or an occupying mass dissecting the infarcted myofibers apart. IMT often contained dense inflammatory cells and blood clot, indicating a dynamic process of thrombus formation and destruction. Notably, IMT was found extending into the cavity to form LVT. Haemodynamic monitoring by telemetry revealed that rupture occurred either as a single event or recurrent episodes. Importantly, the anti-platelet drug clopidogrel, but not aspirin, reduced the prevalence of rupture (10% vs. 45%) and IMT, and suppressed the degree of inflammation. Thus, IMT is a key pathological element in the infarcted heart closely associated with the complications of rupture and LVT. IMT could be either triggered by a wall tear or act as initiator of rupture. IMT may propagate towards the ventricular chamber to trigger LVT.

Keywords

Myocardial infarction - intramural thrombus - left ventricular thrombus - ventricular rupture - platelet - inflammation - anti-platelet drugs - haemodynamics

• References

• 1 Becker RC, Gore JM, Lambrew C. et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 1996; 27: 1321-1326.
• 2 Figueras J, Alcalde O, Barrabes JA. et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation 2008; 118: 2783-2789.
• 3 Porter A, Kandalker H, Iakobishvili Z. et al. Left ventricular mural thrombus after anterior ST-segment-elevation acute myocardial infarction in the era of aggressive reperfusion therapy- still a frequent complication. Cor Artery Dis 2005; 16: 275-279.
• 4 van Dantzig JM, Delemarre BJ, Bot H. et al. Left ventricular thrombus in acute myocardial infarction. Eur Heart J 1996; 17: 1640-1645.
• 5 Domenicucci S, Chiarella F, Bellotti P. et al. Early appearance of left ventricular thrombi after anterior myocardial infarction: a marker of higher in-hospital mortality in patients not treated with antithrombotic drugs. Eur Heart J 1990; 11: 51-58.
• 6 Osherov AB, Borovik-Raz M, Aronson D. et al. Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era. Am Heart J 2009; 157: 1074-1080.
• 7 Rabbani L, Waksmonski C, Iqbal S. et al. Determinants of left ventricular thrombus formation after primary percutaneous coronary intervention for anterior wall myocardial infarction. J Thromb Thrombol 2008; 25: 141-145.
• 8 Küpper AJ, Verheugt FW, Peels CH. et al. Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation. J Am Coll Cardiol 1989; 13: 1514-1520.
• 9 Hutchins KD, Skurnick J, Lavenhar M. et al. Cardiac rupture in acute myocardial infarction: a reassessment. Am J Forensic Med Pathol 2002; 23: 78-82.
• 10 Spirito P, Bellotti P, Chiarella F. et al. Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study. Circulation 1985; 72: 774-780.
• 11 Fang L, Gao XM, Moore XL. et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007; 43: 535-544.
• 12 Gao XM, Xu Q, Kiriazis H. et al. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 2005; 65: 469-477.
• 13 Heymans S, Luttun A, Nuyens D. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999; 5: 1135-1142.
• 14 Matsumura S, Iwanaga S, Mochizuki S. et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest. 2005; 115: 599-609.
• 15 Kameda K, Matsunaga T, Abe N. et al. Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture. Circ J 2006; 70: 673-678.
• 16 van den Borne SWM, Cleutjens JPM, Hanemaaijer R. et al. Increased matrix metalloproteinase-8 and –9 activity in patients with infarct rupture after myocardial infarction. Cardiovascr Pathol 2008; 18: 37-43.
• 17 Zidar N, Jeruc J, Balazic J. et al. Neutrophils in human myocardial infarction with rupture of the free wall. Cardiovasc Pathol 2005; 14: 247-250.
• 18 Gao XM, Ming Z, Su Y. et al. Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol 2010; 143: 20-28.
• 19 Head GA, Obeyesekere VR, Jones ME. et al. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity. Endocrinology 2004; 145: 4286-4291.
• 20 Mangin P, Yap CL, Nonne C. et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency. Blood 2006; 107: 4346-4353.
• 21 Evangelista V, Manarini S, Dell’Elba G. et al. Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activation. Thromb Haemost 2005; 94: 568-577.
• 22 Hashimoto M, Sugidachi A, Isobe T. et al. The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: evidence for specific inhibition of P2Y12 receptors by prasugrel. Biochem Pharmacol 2007; 74: 1003-1009.
• 23 Teng CM, Wu CC, Ko FN. et al. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol 1997; 320: 161-166.
• 24 Majno G, Joris I. Hemostasis and thrombosis. In: Cells, Tissues, and Disease. Principles of General Pathology. Blackwell Science; Cambridge, USA: 1996. pp. 609-644.
• 25 Lopez-Sendon J, Gonzalez A, Lopez de Sa E. et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992; 19: 1145-1153.
• 26 Oliva PB, Hammill SC, Edwards WD. Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol 1994; 22: 1518-1519.
• 27 Davies MJ. Thrombosis in acute myocardial infarction and sudden death. Cardiovasc Clin 1987; 18: 151-159.
• 28 Maseri A, Chierchia S, Davies G. Pathophysiology of coronary occlusion in acute infarction. Circulation 1986; 73: 233-239.
• 29 Sharpe N. Ventricular remodeling following myocardial infarction. Am J Cardiol 1992; 70: 20C-26C.
• 30 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
• 31 von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.
• 32 Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2007; 21: 99-111.
• 33 Muhlestein JB. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost 2010; 103: 71-82.
• 34 Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983; 90-102.
• 35 Takada A, Saito K, Murai T, Ro A, Hamamatsu A. Pathological evaluation of coronary lesions in cases of cardiac rupture during acute myocardial infarction: an autopsy study of 148 out-of-hospital sudden death cases. Pathol Res Pract 2009; 205: 241-247.
• 36 da Trindade M, Tsutsui J, Rodrigues A. et al. Left ventricular free wall impeding rupture in post-myocardial infarction period diagnosed by myocardial contrast echocardiography: Case report. Cardiovasc Ultrasound 2006; 4: 7.
• 37 Mann JM, Roberts WC. Rupture of the left ventricular free wall during acute myocardial infarction: analysis of 138 necropsy patients and comparison with 50 necropsy patients with acute myocardial infarction without rupture. Am J Cardiol 1988; 62: 847-859.
• 38 Ganame J, Messalli G, Dymarkowski S. et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 152: 75-84.
• 39 López-Sendón J, Gurfinkel EP, Lopez de Sa E. et al. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J 2010; 31: 1449-1456.
• 40 Chen ZM, Jiang LX, Chen YP. et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607-1621.